Coagulation profile of liquid-state plasma

Transfusion

Volumn 53, Issue 3, 2013, Pages 579-590

  Gosselin, Robert C ^b   Marshall, Carol ^b   Dwyre, Denis M ^b   Gresens, Chris ^b   Davis, Diana ^b   Scherer, Lynette ^b   Taylor, Douglas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BloodSource   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; D DIMER; FIBRINOLYTIC FACTOR; PROTEIN S; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD; BLOOD CLOTTING; BLOOD GROUP; BLOOD SAMPLING; BLOOD STORAGE; CONTROLLED STUDY; FREEZING; HUMAN; HUMAN EXPERIMENT; LIQUID STATE PLASMA; MALE; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PLASMA; PROTHROMBIN TIME;

ADULT; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; BLOOD PRESERVATION; FIBRINOLYTIC AGENTS; HEMOSTASIS; HUMANS; MALE; PARTIAL THROMBOPLASTIN TIME; PLASMA; PROTEOLYSIS; PROTHROMBIN TIME;

EID: 84874950101     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03772.x     Document Type: Article

References (56)

1. Strumia MM, McGraw JJ,. The development of plasma preparations for transfusions. Ann Intern Med 1941; 15: 80-8.
2. United States Army Medical Department, Office of Medical History. Blood program in World War II. Chapter XI: The plasma program. 1964. [cited 2012 Apr 23]. Available from: URL: http://history.amedd.army.mil/booksdocs/wwii/blood/ chapter11.htm
3. Tatum WL, Elliott J, Nesset N,. The use of plasma as a substitute for whole blood. Anesthesiology 1940; 1: 363-6.
4. Lozner EL, Newhouser LR,. Preservation of normal human plasma in the liquid state. I. A statistical study of 1751 administrations. J Clin Invest 1944; 23: 343-9.
5. Wallis JP, Dzik S,. Is fresh frozen plasma overtransfused in the United States? Transfusion 2004; 44: 1674-5.
6. American Association of Blood Banks. Circular of information for the use of human blood and blood products. Bethesda (MD): American Association of Blood Banks; 2009.
7. Rock G,. A comparison of methods of pathogen inactivation of FFP. Vox Sang 2011; 100: 169-78.
8. Bostrom F, Sjodahl M, Wehlin L, Egberg N, Lundahl J,. Coagulation parameters in apheresis and leukodepleted whole-blood plasma during storage. Transfusion 2007; 47: 460-3.
9. Heger A, Romisch J, Svae TE,. Stability of solvent/detergent-treated plasma and single-donor fresh-frozen plasma during 48 h after thawing. Transfus Apher Sci 2005; 33: 257-67.
10. Alhumaidan H, Cheves T, Holme S, Sweeney J,. Stability of coagulation factors in plasma prepared after a 24-hour room temperature hold. Transfusion 2010; 50: 1934-42.
11. Hellstern P, Haubelt H,. Manufacture and composition of fresh frozen plasma and virus-inactivated therapeutic plasma preparations: correlation between composition and therapeutic efficacy. Thromb Res 2002; 107 Suppl 1: S3-8.
12. Cardigan R, Van der Meer PF, Pergande C, Cookson P, Baumann-Baretti B, Cancelas JA, Devine D, Gulliksson H, Vassallo R, de Wildt-Eggen J,. Coagulation factor content of plasma produced from whole blood stored for 24 hours at ambient temperature: results from an international multicenter BEST Collaborative study. Transfusion 2011; 51 Suppl 1: 50S-7S.
13. Downes KA, Wilson E, Yomtovian R, Sarode R,. Serial measurement of clotting factors in thawed plasma stored for 5 days. Transfusion 2001; 41: 570.
14. Shaz BH, Stowell SR, Hillyer CD,. Transfusion-related acute lung injury: from bedside to bench and back. Blood 2011; 117: 1463-71.
15. Gonzalez EA, Moore FA, Holcomb JB, Miller CC, Kozar RA, Todd SR, Cocanour CS, Balldin BC, McKinley BA,. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma 2007; 62: 112-9.
16. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, Sebesta J, Jenkins D, Wade CE, Holcomb JB,. The ratio of blood products transfused affectsmortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 63: 805-13.
17. Roback JD, Caldwell S, Carson J, Davenport R, Drew MJ, Eder A, Fung M, Hamilton M, Hess JR, Luban N, Perkins JG, Sachais BS, Shander A, Silverman T, Snyder E, Tormey C, Waters J, Djulbegovic B,. Evidence-based practice guidelines for plasma transfusion. Transfusion 2010; 50: 1227-39.
18. Phan HH, Wisner DH,. Should we increase the ratio of plasma/platelets to red blood cells in massive transfusion: what is the evidence? Vox Sang 2010; 98: 395-402.
19. Stansbury LG, Dutton RP, Stein DM, Bochicchio GV, Scalea TM, Hess JR,. Controversy in trauma resuscitation: do ratios of plasma to red blood cells matter? Transfus Med Rev 2009; 23: 255-65.
20. American Association of Blood Banks. Standards for blood banks and transfusion services. American Association of Blood Banks, editor. Bethesda (MD): American Association of Blood Banks; 2011.
21. Dating periods for licensed biological products, 21 CFR 610.53(c) (2011).
22. Burtelow M, Riley E, Druzin M, Fontaine M, Viele M, Goodnough LT,. How we treat: management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol. Transfusion 2007; 47: 1564-72.
23. Kakaiya R, Aronson CA, Julleis J,. Whole blood collection and component processing at blood collection centers. In:, Roback JD, editor. AABB technical manual. Bethesda (MD): American Association of Blood Banks; 2011. p. 198-204.
24. Hemker HC, Wielders S, Kessels H, Beguin S,. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993; 70: 617-24.
25. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR,. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
26. Strumia MM, McGraw JJ,. Blood plasma-its place in the practice of medicine, with special consideration to the problems of preservation. J Am Med Assoc 1942; 118: 427-31.
27. Taylor FH, Lozner EL, Davidson CS, Tagnon HJ, Newhouser LR, MacDonald H, Adams MA,. Preservation of normal human plasma in the liquid state. II. Comparative in vitro-studies on the physiologic activity of labile constituents of liquid and frozen plasma. J Clin Invest 1944; 23: 351-6.
28. Smak Gregoor PJ, Harvey MS, Briet E, Brand A,. Coagulation parameters of CPD fresh-frozen plasma and CPD cryoprecipitate-poor plasma after storage at 4 degrees C for 28 days. Transfusion 1993; 33: 735-8.
29. Runkel S, Haubelt H, Hitzler W, Hellstern P,. The quality of plasma collected by automated apheresis and of recovered plasma from leukodepleted whole blood. Transfusion 2005; 45: 427-32.
30. Cid J, Ramiro L, Martinez N, Palomo M, Magallon O, Claparols M, Ortiz P, Puig L, Pla RP,. Quantitative and qualitative analysis of proteins in fresh frozen plasma obtained from whole blood donations and prepared with two photochemical treatments. Transfus Apher Sci 2008; 39: 115-21.
31. Gatt A, van Veen JJ, Woolley AM, Kitchen S, Cooper P, Makris M,. Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro. Thromb Haemost 2008; 100: 350-5.
32. Dunbar NM, Chandler WL,. Thrombin generation in trauma patients. Transfusion 2009; 49: 2652-60.
33. al Dieri R, Alban S, Beguin S, Hemker HC,. Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time. J Thromb Haemost 2004; 2: 1395-401.
34. Suontaka AM, Silveira A, Soderstrom T, Blomback M,. Occurrence of cold activation of transfusion plasma during storage at +4 degrees C. Vox Sang 2005; 88: 172-80.
35. MacLeod JB,. Trauma and coagulopathy: a new paradigm to consider. Arch Surg 2008; 143: 797-801.
36. Frith D, Brohi K,. The acute coagulopathy of trauma shock: clinical relevance. Surgeon 2010; 8: 159-63.
37. Brohi K, Cohen MJ, Davenport RA,. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care 2007; 13: 680-5.
38. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF,. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg 2007; 245: 812-8.
39. Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC, Pittet JF,. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008; 64: 1211-7; discussion 1217.
40. Frith D, Goslings JC, Gaarder C, Maegele M, Cohen MJ, Allard S, Johansson PI, Stanworth S, Thiemermann C, Brohi K,. Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations. J Thromb Haemost 2010; 8: 1919-25.
41. Floccard B, Rugeri L, Faure A, Denis MS, Boyle EM, Peguet O, Levrat A, Guillaume C, Marcotte G, Vulliez A, Hautin E, David JS, Negrier C, Allaouchiche B,. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury 2012; 43: 26-32.
42. Yuan S, Ferrell C, Chandler WL,. Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma. Thromb Res 2007; 120: 29-37.
43. De Oliveira CO, Reimer AG, Da Rocha AB, Grivicich I, Schneider RF, Roisenberg I, Regner A, Simon D,. Plasma von Willebrand factor levels correlate with clinical outcome of severe traumatic brain injury. J Neurotrauma 2007; 24: 1331-8.
44. Siemiatkowski A, Kloczko J, Galar M, Czaban S,. von Willebrand factor antigen as a prognostic marker in posttraumatic acute lung injury. Haemostasis 2000; 30: 189-95.
45. Sheth SB, Carvalho AC,. Protein S and C alterations in acutely ill patients. Am J Hematol 1991; 36: 14-9.
46. Boldt J, Papsdorf M, Rothe A, Kumle B, Piper S,. Changes of the hemostatic network in critically ill patients-is there a difference between sepsis, trauma, and neurosurgery patients? Crit Care Med 2000; 28: 445-50.
47. Yuan S, Ziman A, Anthony MA, Tsukahara E, Hopkins C, Lu Q, Goldfinger D,. How do we provide blood products to trauma patients? Transfusion 2009; 49: 1045-9.
48. Kitchens CS,. Surgery and hemostasis. In:, Kitchens CS, Barbara M, Kessler CM, editors. Consultative hemostasis and thrombosis. Philadelphia (PA): Saunders/Elsevier; 2007. p. 613-34.
49. Zimrin AB, Holcomb JB, Hess JR,. Hemorrhage control and thrombosis following severe injury. In:, Kitchens CS, Barbara M, Kessler CM, editors. Consultative hemostasis and thrombosis. Philadelphia (PA): Saunders/Elsevier; 2007. p. 718-9.
50. Wohlauer MV, Moore EE, Droz NM, Harr J, Gonzalez E, Fragoso M, Silliman CC,. Hemodilution is not critical in the pathogenesis of the acute coagulopathy of trauma. J Surg Res 2012; 173: 26-30.
51. Harr JN, Moore EE, Wohlauer MV, Droz N, Fragoso M, Banerjee A, Silliman CC,. The acute coagulopathy of trauma is due to impaired initial thrombin generation but not clot formation or clot strength. J Surg Res 2011; 170: 319-24.
52. Pati S, Matijevic N, Doursout MF, Ko T, Cao Y, Deng X, Kozar RA, Hartwell E, Conyers J, Holcomb JB,. Protective effects of fresh frozen plasma on vascular endothelial permeability, coagulation, and resuscitation after hemorrhagic shock are time dependent and diminish between days 0 and 5 after thaw. J Trauma 2010; 69 Suppl 1: S55-63.
53. Haywood-Watson RJ, Holcomb JB, Gonzalez EA, Peng Z, Pati S, Park PW, Wang W, Zaske AM, Menge T, Kozar RA,. Modulation of syndecan-1 shedding after hemorrhagic shock and resuscitation. PLoS ONE 2011; 6: e23530.
54. Bux J, Sachs UJ,. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007; 136: 788-99.
55. Bercovitz RS, Kelher MR, Khan SY, Land KJ, Berry TH, Silliman CC,. The pro-inflammatory effects of platelet contamination in plasma and mitigation strategies for avoidance. Vox Sang 2012; 102: 345-53.
56. Gilliss BM, Looney MR,. Experimental models of transfusion-related acute lung injury. Transfus Med Rev 2011; 25: 1-11.